We have more than 10 years of experience in custom synthesis of compounds. If you are looking for a supplier or manufacturer of Axitinib (CAS No.: 319460-85-0) please contact us. We can provide customers with custom synthesis from grams to kilograms and the production of tons of compounds. Now, we also hope to meet your needs for Axitinib (CAS No.: 319460-85-0) and other compounds. We can provide high-quality compounds and good service for you.
Name |
Axitinib |
Synonyms |
AG-013736 N-Methyl-2-((3-((1E)-2-(pyridin-2-yl)ethenyl)-1H-indazol-6-yl)sulfanyl)benzamide;AXITINIB;Axtinib;AVERMECTINB;[14C]-Axitinib;Axitinib (usan) |
Molecular Formula |
C22H18N4OS |
Molecular Weight |
386.47000 |
CAS Number |
319460-85-0 |
purity |
≥98% |
Storage conditions |
Sealed in dry,2-8°C |
application:Axitinib
(AG013736; trade name Inlyta) (CAS No.: 319460-85-0) is a small molecule tyrosine kinase inhibitor
developed by Pfizer. It has been shown to significantly inhibit growth of
breast cancer in animal (xenograft) models and has shown partial responses in
clinical trials with renal cell carcinoma (RCC) and several other tumour types.
It was approved for RCC by the U.S. Food and
Drug Administration after showing a modest increase in progression-free
survival, though there have been reports of fatal adverse effects.